sarepta ceo doug ingram: we should be profitable by the end of next year if we achieve our goals
Published 1 year ago • 1.2K plays • Length 3:31Download video MP4
Download video MP3
Similar videos
-
5:43
sarepta ceo on what's next after expanded muscular dystrophy drug approval
-
4:09
watch cnbc's full interview with sarepta ceo doug ingram
-
3:18
sarepta therapeutics ceo on soaring stock and drug development
-
2:30
wsb investor call | june 21, 2022 - call preview with david maris and sarepta ceo douglas s. ingram.
-
2:44
private payrolls show better-than-expected growth of 143,000 in september, adp says
-
38:28
iranian ballistic missile barrage overwhelms israeli air defence,what lesson does it hold for india?
-
10:42
will israel strike iran's nuclear sites? hear what expert thinks
-
2:48
warehouses could be a big winner from port strikes, in the short-term
-
6:41
former fda commissioner dr. scott gottlieb on the future of gene therapy
-
3:40
oil and gas assets will have a multi-year boon cycle, says rapidan's bob mcnally
-
7:07
roche has over five weight-loss companion medicines, ceo says
-
4:00
market is validating value of standardaero, ceo says
-
4:18
guggenheim’s bob drbul on nike q1 results: still a very tough task at hand for new ceo elliott hill
-
6:35
prothena corporation ceo: biotech breakthrough | mad money | cnbc
-
4:06
hp unveils new ai-powered tech that is shaping our future | san diego living
-
3:24
i don't see how we get to 2% inflation without a recession, says crossmark ceo bob doll
-
4:20
hearst ceo steve swartz: this is a golden age to be a consumer of television | cnbc
-
3:07
unilever ceo: this is 'once in two-decade inflationary pressure'
-
2:47
sarepta shares tumble as concerns mount over fda approval on gene therapy
-
7:53
why ford is 'a benefit' for investors: analyst
-
1:32
spartannash ceo says he's concerned about 'spiral inflation' in food